Diversity of clostridium difficile PCR ribotypes in europe: Results from the European, multicentre, prospective, biannual, point-prevalence study of clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013

Eurosurveillance

Volumn 21, Issue 29, 2016, Pages

  Davies, K A ^a   Ashwin, H ^a   Longshaw, C M ^b   Burns, D A ^b   Davis, G L ^a   Wilcox, M H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Astellas Pharma EMEA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; HOSPITALIZATION; HUMAN; MULTICENTER STUDY; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; RIBOTYPING; CLASSIFICATION; CLINICAL TRIAL; CLOSTRIDIUM INFECTIONS; CROSS-SECTIONAL STUDY; EUROPE; FECES; GENETICS; HEALTH SURVEY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATIENT;

BACTERIAL TOXIN;

BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS-SECTIONAL STUDIES; DIARRHEA; EUROPE; FECES; HUMANS; PATIENTS; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RIBOTYPING;

EID: 85015141952     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.29.30294     Document Type: Article

References (35)

1. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals 2011–2012. Stockholm: ECDC; 2013. Available from: http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90andID=865?
2. Schmid D, Kuo HW, Simons E, Kanitz EE, Wenisch J, Allerberger F, et al. All-cause mortality in hospitalized patients with infectious diarrhea: Clostridium difficile versus other enteric pathogens in Austria from 2008 to 2010. J Infect Public Health. 2014;7(2):133-44. DOI: 10.1016/j.jiph.2013.07.010. PMID: 24231157
3. Wenisch JM, Schmid D, Tucek G, Kuo HW, Allerberger F, Michl V, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2012;40(5):479-84. DOI: 10.1007/s15010-012-0258-1. PMID: 22527876
4. Hensgens MPM, Goorhuis A, Dekkers OM, van Benthem BHB, Kuijper EJ. All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis. 2013;56(8):1108-16. DOI: 10.1093/cid/cis1209. PMID: 23300235
5. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis. 2013;13(11):936-45. DOI: 10.1016/S1473-3099(13)70200-7. PMID: 24007915
6. Valiente E, Dawson LF, Cairns MD, Stabler RA, Wren BW. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage.J Med Microbiol. 2012;61(Pt 1):49-56. DOI: 10.1099/jmm.0.036194-0. PMID: 21903827
7. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcareassociated Clostridium difficile. Nat Genet. 2013;45(1):109-13. DOI: 10.1038/ng.2478. PMID: 23222960
8. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7(7):526-36. DOI: 10.1038/nrmicro2164. PMID: 19528959
9. Valiente E, Cairns MD, Wren BW. The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move. Clin Microbiol Infect. 2014;20(5):396-404. DOI: 10.1111/1469-0691.12619. PMID: 24621128
10. Goorhuis A, Van der Kooi T, Vaessen N, Dekker FW, Van den Berg R, Harmanus C, et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis. 2007;45(6):695-703. DOI: 10.1086/520984. PMID: 17712752
11. Bauer MP, Notermans DW, van Benthem BHB, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73. DOI: 10.1016/S0140-6736(10)61266-4. PMID: 21084111
12. Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14(12):1208-19. DOI: 10.1016/S1473-3099(14)70991-0. PMID: 25455988
13. Alcalá L, Martín A, Marín M, Sánchez-Somolinos M, Catalán P, Peláez T, et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin Microbiol Infect. 2012;18(7):E204-13. DOI: 10.1111/j.1469-0691.2012.03883.x. PMID: 22563775
14. Enoch DA, Butler MJ, Pai S, Aliyu SH, Karas JA. Clostridium difficile in children: colonisation and disease. J Infect. 2011;63(2):105-13. DOI: 10.1016/j.jinf.2011.05.016. PMID: 21664931
15. Faust SN, Wilcox MH, Banaszkiewicz A, Bouza E, Raymond J, Gerding DN. Lack of evidence for an unmet need to treat Clostridium difficile infection in infants aged <2 years: expert recommendations on how to address this issue. Clin Infect Dis. 2015;60(6):912-8. DOI: 10.1093/cid/ciu936. PMID: 25422389
16. de Graaf H, Pai S, Burns DA, Karas JA, Enoch DA, Faust SN. Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. Eur J Clin Microbiol Infect Dis. 2015;34(7):1281-7. DOI: 10.1007/s10096-015-2367-0. PMID: 25926302
17. Fawley WN, Knetsch CW, MacCannell DR, Harmanus C, Du T, Mulvey MR, et al. Development and validation of an internationally-standardized, high-resolution capillary gelbased electrophoresis PCR-ribotyping protocol for Clostridium difficile. PLoS One. 2015;10(2):e0118150. DOI: 10.1371/journal.pone.0118150. PMID: 25679978
18. United Nations Statistics Division. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. Revised 31 Oct 2013. New York: United Nations. [Accessed 30 Jan 2015]. Available from: http://unstats.un.org/unsd/methods/m49/m49regin.htm
19. Nyč O, Pituch H, Matějková J, Obuch-Woszczatynski P, Kuijper EJ. Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet. 2011;377(9775):1407. DOI: 10.1016/S0140-6736(11)60575-8. PMID: 21515161
20. Krutova M, Matejkova J, Nyc O. C. difficile ribotype 027 or 176? Folia Microbiol (Praha). 2014;59(6):523-6. DOI: 10.1007/s12223-014-0323-5. PMID: 24970104
21. Ashwin H, Davies KA, Davis GL, Lee F, Longshaw CM, Wilcox MH. Optimised diagnosis of Clostridium difficile infection; is there still room for improvement? Results of a European point prevalence study of C. difficile infection (EUCLID). Poster presented at 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 10-13 May 2014, Barcelona, Spain. P0738.
22. Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol. 2009;47(10):3211-7. DOI: 10.1128/JCM.01082-09. PMID: 19710274
23. Brazier JS, Patel B, Pearson A. Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro Surveill. 2007;12(4):E070426.2.PMID: 17868609
24. Brazier JS, Raybould R, Patel B, Duckworth G, Pearson A, Charlett A, et al. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill. 2008;13(41):19000.PMID: 18926105
25. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotypingbased surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056-63. DOI: 10.1093/cid/cis614. PMID: 22784871
26. Public Health England (PHE). Clostridium difficile Ribotyping Network (CDRN) for England and Northern Ireland. 2011-13 report. London: PHE; 2014. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/329156/C_difficile_ribotyping_network_CDRN_report.pdf
27. Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J, ARHAI Antimicrobial Stewardship Group. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother. 2012;67(Suppl 1):i51-63. DOI: 10.1093/jac/dks202. PMID: 22855879
28. Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50(2):194-201. DOI: 10.1086/649213. PMID: 20025526
29. Ludlam H, Brown N, Sule O, Redpath C, Coni N, Owen G. An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea.Age Ageing. 1999;28(6):578-80. DOI: 10.1093/ageing/28.6.578. PMID: 10604512
30. Wilcox MH, Freeman J, Fawley W, MacKinlay S, Brown A, Donaldson K, et al. Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother. 2004;54(1):168-72. DOI: 10.1093/jac/dkh285. PMID: 15163654
31. Eyre DW, Walker AS, Griffiths D, Wilcox MH, Wyllie DH, Dingle KE, et al. Clostridium difficile mixed infection and reinfection. J Clin Microbiol. 2012;50(1):142-4. DOI: 10.1128/JCM.05177-11. PMID: 22075589
32. Tanner HE, Hardy KJ, Hawkey PM. Coexistence of multiple multilocus variable-number tandem-repeat analysis subtypes of Clostridium difficile PCR ribotype 027 strains within fecal specimens. J Clin Microbiol. 2010;48(3):985-7. DOI: 10.1128/JCM.02012-09. PMID: 20071546
33. Wroblewski D, Hannett GE, Bopp DJ, Dumyati GK, Halse TA, Dumas NB, et al. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J Clin Microbiol. 2009;47(7):2142-8. DOI: 10.1128/JCM.02498-08. PMID: 19403775
34. Broukhanski G, Simor A, Pillai DR. Defining criteria to interpret multilocus variable-number tandem repeat analysis to aid Clostridium difficile outbreak investigation. J Med Microbiol. 2011;60(Pt 8):1095-100. DOI: 10.1099/jmm.0.029819-0. PMID: 21474615
35. van den Berg RJ, Ameen HA, Furusawa T, Claas EC, van der Vorm ER, Kuijper EJ. Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol. 2005;54(Pt 2):173-9. DOI: 10.1099/jmm.0.45825-0. PMID: 15673513